The global mast cell tumor treatment market is set to experience steady growth, with its value expected to rise from USD 5,609.4 million in 2024 to USD 7,836.4 million by 2034, reflecting a compound annual growth rate (CAGR) of 3.4% during the forecast period. This growth is driven by advancements in diagnostic technologies and the …